Ion Beam ApplicationsIOBCF 82 ROE % is 25.02% as of Dec. 2025, which is 313% above its 10-year median of 6.06. GuruFocus rates IOBCF with a GF Score™ of 82/100 and a GF Value™ of $18.71 (Fairly Valued). The stock has 10 warning signs investors should review. Among 799 Medical Devices & Instruments companies, Ion Beam Applications ranks better than 76.6% on this metric.
The historical rank and industry rank for Ion Beam Applications's ROE % or its related term are showing as below:
IOBCF'
s ROE % Range Over the Past 10 Years
Min: -30.26 Med: 6.06 Max: 25.22
Current: 10.7
During the past 13 years, Ion Beam Applications's highest ROE % was 25.22%. The lowest was -30.26%. And the median was 6.06%.
IOBCF's ROE % is ranked better than 76.6% of 799
companies
in the Medical Devices & Instruments industry
Industry Median: 2.42
vs IOBCF: 10.70
Ion Beam Applications (OTCPK:IOBCF) ROE % Explanation
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is two times the semi-annual (Dec. 2025) net income data. The Revenue data used here is two times the semi-annual (Dec. 2025) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Ion Beam Applications's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ion Beam Applications ROE % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Ion Beam Applications's ROE % distribution charts can be found below:
* The bar in red indicates where Ion Beam Applications's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is two times the semi-annual (Dec. 2025) net income data.
ROE % is displayed in the 30-year financial page.
Ion Beam Applications (IOBCF) has a ROE % of 25.02% as of Dec. 2025. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Ion Beam Applications and its competitors. This is 313% above median its historical median of 6.06. According to the industry distribution chart, Ion Beam Applications ranks #187 out of 799 companies in the Medical Devices & Instruments industry, placing it in the top 23.4%.
Is Ion Beam Applications' ROE % too high?
Ion Beam Applications' current ROE % of 25.02% is 313% above median its 10-year median of 6.06. The Medical Devices & Instruments industry median ROE % is 2.42. Ion Beam Applications' value of 25.02% is 933.9% above this industry median. Based on the distribution chart, Ion Beam Applications ranks #187 out of 799 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Ion Beam Applications has a GF Score™ of 82/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Ion Beam Applications' ROE % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Ion Beam Applications ranks #187 out of 799 companies for ROE %. This places Ion Beam Applications in the top 23% of its industry — outperforming the majority of peers. The industry median ROE % is 2.42. Ion Beam Applications' value of 25.02% is 933.9% above this benchmark. While the company's 10-year median is 6.06 vs. the industry median of 2.42, Ion Beam Applications has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Medical Devices & Instruments company?
The median ROE % among Medical Devices & Instruments companies is 2.42, based on 799 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ion Beam Applications's current ROE % of 25.02% is 933.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Ion Beam Applications and its competitors. For the Medical Devices & Instruments industry, the median ROE % is 2.42 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ion Beam Applications's current ROE % is 25.02%, which is 313% above median its own 10-year median of 6.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ion Beam Applications stock overvalued right now?
Based on GuruFocus' analysis, Ion Beam Applications (IOBCF) is currently considered Fairly Valued. The stock's GF Value™ is $18.71, compared to a current price of $18.50 — trading 1.1% below its estimated fair value. The current ROE % is 25.02%, which is 313% above median its 10-year median of 6.06 and 933.9% above the Medical Devices & Instruments industry median of 2.42. Ion Beam Applications' overall GF Score™ is 82/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Ion Beam Applications (IOBCF), the current ROE % is 25.02% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ion Beam Applications (IOBCF) Overvalued in 2026?
Based on GuruFocus' analysis, Ion Beam Applications stock appears to be undervalued.
The current stock price of $18.50 is trading 1.1% below its estimated GF Value™ of $18.71.
GuruFocus considers Ion Beam Applications to be Fairly Valued.
Key valuation signals for IOBCF:
ROE %: 25.02% (313% above median its 10-year median of 6.06)
GF Value™: $18.71 vs. price of $18.50 (1.1% below fair value)
Industry Position: 933.9% above the Medical Devices & Instruments median (#187 of 799)
No single metric tells the full story. See the IOBCF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ion Beam Applications SA develops and manufactures medical devices and software solutions. The firm operates in three segments: IBA Clinical, including Proton Therapy and Dosimetry; IBA Technologies; and IBA Corporate. Proton therapy and other accelerators contribute to the majority of sales. It offers solutions for precision cancer treatment through the use of proton beams, as well as cyclotrons used for the production of radioisotopes and industrial accelerators for sterilization and ionization. The dosimetry business sells measurement and quality assurance instruments for radiotherapy and medical imaging. The firm operates in three geographical areas: Belgium, the United States, China, Germany, and India.
82GF Score
Get the complete analysis for IOBCF
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IOBCF has been successfully added to your 
